Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography. (Q48400458)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2014

Language	Label	Description	Also known as
English	Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography.	scientific article published in April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

florbetapir (18F)

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ing-Tsung Hsiao

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Kuan-Yi Wu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Cheng-Sheng Chen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Chia-Hsiang Chen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Chia-Ju Hsieh

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yau-Yau Wai

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Chee-Jen Chang

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hsiao-Jung Tseng

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tzue-Chen Yen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Chia-Yih Liu

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 April 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

41

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

714-722

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24233127%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

https://scigraph.springernature.com/pub.10.1007/s00259-013-2627-0

0 references

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

History of depression as a risk factor for dementia: an updated review.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Enduring increased risk of developing depression and mania in patients with dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

PET of brain amyloid and tau in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Subtypes of mild cognitive impairment among the elderly with major depressive disorder in remission.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Persistent mild cognitive impairment in geriatric depression

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Midlife cardiovascular risk factors and risk of dementia in late life

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Current concepts in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Unified segmentation

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Lack of association between prior depressive episodes and cerebral [11C]PiB binding.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

The precuneus: a review of its functional anatomy and behavioural correlates

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Questionable dementia: clinical course and predictors of outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Molecular polymorphism of Abeta in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Probability of stroke: a risk profile from the Framingham Study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2627-0

21 January 2018

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24233127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of Alzheimer's disease in a community hospital-based brain bank program

1 reference

https://pubmed.ncbi.nlm.nih.gov/24233127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24233127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of dementia in an urban area in taiwan.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24233127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging of Alzheimer-related cortical destruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24233127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24233127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48400458&oldid=1509872093"